Ignite Creation Date:
2024-05-05 @ 5:28 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00469976
Status:
WITHDRAWN
Last Update Posted:
2015-10-08
First Post:
2007-05-03
Brief Title:
Enzastaurin Carboplatin and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Sponsor:
Eastern Cooperative Oncology Group
Organization:
Eastern Cooperative Oncology Group
Organization Data
Organization:
Eastern Cooperative Oncology Group
Class:
NETWORK
Study ID:
CDR0000542546
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Eastern Cooperative Oncology Group
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |